Next Article in Journal
Synthesis, In Vitro, and Computational Studies of PTP1B Phosphatase Inhibitors Based on Oxovanadium(IV) and Dioxovanadium(V) Complexes
Previous Article in Journal
Revisiting Regulated Cell Death Responses in Viral Infections
Previous Article in Special Issue
Targeting Interleukin-10 Restores Graft Microvascular Supply and Airway Epithelium in Rejecting Allografts
 
 
Review
Peer-Review Record

What Inhibits Natural Killers’ Performance in Tumour

Int. J. Mol. Sci. 2022, 23(13), 7030; https://doi.org/10.3390/ijms23137030
by Ines Papak 1, Elżbieta Chruściel 1, Katarzyna Dziubek 1, Małgorzata Kurkowiak 1, Zuzanna Urban-Wójciuk 1, Tomasz Marjański 2, Witold Rzyman 2 and Natalia Marek-Trzonkowska 1,3,*
Reviewer 1: Anonymous
Reviewer 2:
Reviewer 3:
Int. J. Mol. Sci. 2022, 23(13), 7030; https://doi.org/10.3390/ijms23137030
Submission received: 29 April 2022 / Revised: 16 June 2022 / Accepted: 22 June 2022 / Published: 24 June 2022
(This article belongs to the Special Issue Manipulating Immune Tolerance with Cellular Therapies)

Round 1

Reviewer 1 Report

Please, see attached a document with my comments.

Comments for author File: Comments.pdf

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

The review article "What Inhibits Natural Killers' Performance in Tumour" aims at providing the current understanding of the inhibitory signals towards their cytotoxic potential. The authors have done a good job in providing such a detailed review in a simple form that reads well. 

My only minor suggestion would be to include a section about how aging affects the Nk cell functions. Aging itself is associated with a change in Nk cell phenotype and function. Given the aim of the review, adding the aging aspect would help the scientific community to know how a natural event like aging itself affects the cytotoxic potential of these cells. 

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 3 Report

In this article, the authors provide an exhaustive review of mechanisms mediating the inhibition of NK cell activity. A general comment in this work is that the authors could include examples of targeting NK cells in the clinic using immunotherapy as a primary or secondary outcome, if the authors find it fitting. Furthermore, the introduction section should be modified to include a general overview of the manuscript, presenting the specific aims of this work. Importantly, it would greatly benefit the article if the authors presented the information in a more critical manner, also adding a future perspectives section that would present the challenges in targeting NK cells in the tumor microenvironment and how we could possibly overcome them.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop